NCT02986737View on ClinicalTrials.gov

ACURATE Neo™ Aortic Bioprosthesis for Implantation Using the ACURATE TA™ LP Transapical Delivery System in Patients With Severe Aortic Stenosis

NACompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

December 8, 2014

Primary Completion Date

March 3, 2015

Study Completion Date

October 31, 2019

Conditions
Aortic Stenosis
Interventions
DEVICE

ACURATE neo™ and ACURATE TA™ LP

ACURATE neo™ Aortic Bioprosthesis and ACURATE TA™ LP Transapical Delivery System on patients with severe aortic stenosis where conventional aortic valve replacement (AVR) via open-heart surgery is considered to be high risk

Trial Locations (2)

20246

Klinik für Herz-und Gefäßchirurgie, Hamburg

61231

Kerckhoff-Klinik, Bad Nauheim

All Listed Sponsors
lead

Symetis SA

INDUSTRY

NCT02986737 - ACURATE Neo™ Aortic Bioprosthesis for Implantation Using the ACURATE TA™ LP Transapical Delivery System in Patients With Severe Aortic Stenosis | Biotech Hunter | Biotech Hunter